A randomized trial of consensus interferon in combination with ribavirin as initial treatment for chronic hepatitis C.

doi:10.1016/s0168-8278(03)00391-x

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

A randomized trial of consensus interferon in combination with ribavirin as initial treatment for chronic hepatitis C.

Journal of hepatology - 1 Nov 2003

Fattovich Giovanna, Zagni Irene, Minola Eliseo, Felder Martina, Rovere Pierangelo, Carlotto Antonio, Suppressa Sergio, Miracolo Anna, Paternoster Claudio, Rizzo Caterina, Rossini Angelo, Benedetti Paolo, Capanni Marco, Ferrara Chiara, Costa Paolo, Bertin Tosca, Pantalena Maurizio, Lomonaco Lorenzo, Scattolini Chiara, Mazzella Giuseppe, Giusti Massimo, Boccia Sergio, Milani Stefano, Marin Renato, Lisa Ribero Maria, Tagger Alessandro

Abstract excerpt

BACKGROUND/AIMS: The aim of the present, open-labeled, randomized study was to determine the efficacy and safety of different doses of consensus interferon plus ribavirin in the initial treatment of chronic hepatitis C. METHODS: One hundred and one genotype 2/3 patients were randomized to receive 9 mcg (group A, n=48) or 18 mcg (group B, n=53) of consensus interferon thrice weekly plus ribavirin (1000/1200...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Administration Schedule

Share to Drug Therapy, Combination

Share to Hepatitis C, Chronic

Share to Interferon-alpha

Share to Interferon Type I

Share to Patient Compliance

Share to Ribavirin

Source

Open in PubMed

Identifiers

PMID: 14568269
DOI: 10.1016/s0168-8278(03)00391-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A randomized trial of consensus interferon in combination with ribavirin as initial treatment for chronic hepatitis C.PMID 14568269Read ↗

Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group.Semantic proximity Read ↗

Re-treatment of chronic hepatitis C with consensus interferon .Semantic proximity Read ↗

Recent i.v.-drug users with chronic hepatitis C can be efficiently treated with daily high dose induction therapy using consensus interferon: an open-label pilot study.Semantic proximity Read ↗

Consensus interferon used to treat prior partial-responders to pegylated interferon plus ribavirin.Semantic proximity Read ↗

Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: a randomized open-label pilot study.Semantic proximity Read ↗

Hepatitis C virus genotype 3: Meta-analysis on sustained virologic response rates with currently available treatment options.Semantic proximity Read ↗

Daily interferon monotherapy for chronic hepatitis C in patients with normal or near-normal serum alanine transaminase levels: a comparison of two protocols.Semantic proximity Read ↗

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT)Semantic proximity Read ↗

Efficacy and cost-effectiveness of consensus interferon monotherapy with high-dose induction for hepatitis C patients with genotype 2.Semantic proximity Read ↗

Daily induction combination treatment with alpha 2b interferon and ribavirin or standard combination treatment in naive chronic hepatitis C patients. A multicentre randomized controlled trial.Semantic proximity Read ↗

A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C not responding to interferon alone.Semantic proximity Read ↗

Daily or three times a week interferon alfa-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.